<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    CohBar, Inc.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About CohBar, Inc.

    CohBar, Inc. is a leader in the research and development of mitochondria based therapeutics (MBTs), an emerging class of drugs with the potential to treat a wide range of diseases associated with aging and metabolic dysfunction including non-alcoholic steatohepatitis (NASH), obesity, Type 2 diabetes (T2D), cancer, cardiovascular disease and CNS disorders. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Steven B. Engle, M.S.
    • FOUNDED
      2007
    • EMPLOYEES
      20
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    Principia Biopharma Inc.

    Principia Biopharma Inc.

    We are a late-stage biopharmaceutical company dedicated to bringing transformative...

    We are a late-stage biopharmaceutical company d...

    Filing Type:    PU
    CareTrust REIT, Inc.

    CareTrust REIT, Inc.

    CareTrust REIT, Inc. is a self-administered, publicly-traded real estate investmen...

    CareTrust REIT, Inc. is a self-administered, pu...

    Filing Type:    PU
    Tabula Rasa HealthCare, Inc.

    Tabula Rasa HealthCare, Inc.

    Tabula Rasa HealthCare (TRHC) is a leader in providing patient-specific, data-driv...

    Tabula Rasa HealthCare (TRHC) is a leader in pr...

    Filing Type:    PU
    Arena Pharmaceuticals, Inc.

    Arena Pharmaceuticals, Inc.

    Arena Pharmaceuticals is driven to deliver novel, transformational medicines with ...

    Arena Pharmaceuticals is driven to deliver nove...

    Filing Type:    PU
    Karyopharm Therapeutics Inc.

    Karyopharm Therapeutics Inc.

    Karyopharm Therapeutics is an innovation-driven pharmaceutical company focused on ...

    Karyopharm Therapeutics is an innovation-driven...

    Filing Type:    PU
    Rubius Therapeutics, Inc.

    Rubius Therapeutics, Inc.

    Rubius Therapeutics developed our proprietary RED PLATFORMÂŽ to generate red blood...

    Rubius Therapeutics developed our proprietary R...

    Filing Type:    PU
    AVEO Pharmaceuticals, Inc.

    AVEO Pharmaceuticals, Inc.

    AVEO Pharmaceuticals, Inc. is a biopharmaceutical company seeking to advance targe...

    AVEO Pharmaceuticals, Inc. is a biopharmaceutic...

    Filing Type:    PU
    Agios Pharmaceuticals, Inc.

    Agios Pharmaceuticals, Inc.

    Agios is a biopharmaceutical company passionately committed to applying our scient...

    Agios is a biopharmaceutical company passionate...

    Filing Type:    PU
    Morphic Holding, Inc.

    Morphic Holding, Inc.

    Morphic Therapeutic is leading the development of a new generation of oral integri...

    Morphic Therapeutic is leading the development ...

    Filing Type:    PU
    Valeritas Holdings, Inc.

    Valeritas Holdings, Inc.

    Valeritas is a commercial-stage medical technology company focused on improving he...

    Valeritas is a commercial-stage medical technol...

    Filing Type:    PU
    Beta Bionics, Inc.

    Beta Bionics, Inc.

    Beta Bionics develops an integrated bionic pancreas system called the iLet.

    Beta Bionics develops an integrated bionic panc...

    Amount Raised:    $126,600,000
    Fundraising Status:    SB
    Filing Type:    CF
    Immuron Limited

    Immuron Limited

    Immuron Ltd is a publicly listed Australian biopharmaceutical company focused on o...

    Immuron Ltd is a publicly listed Australian bio...

    Filing Type:    PU
    Athersys, Inc.

    Athersys, Inc.

    We are an international biotechnology company that is focused in the field of rege...

    We are an international biotechnology company t...

    Filing Type:    PU
    Mesoblast Limited

    Mesoblast Limited

    Mesoblast Limited (Nasdaq: MESO; ASX:MSB) is a world leader in developing allogene...

    Mesoblast Limited (Nasdaq: MESO; ASX:MSB) is a ...

    Filing Type:    PU
    CHF Solutions, Inc.

    CHF Solutions, Inc.

    CHF Solutions is focused on improving the quality of life for patients suffering f...

    CHF Solutions is focused on improving the quali...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.